on the option side of pfizer.till ahead, amgen shares surging this week and hitting a high in today's session. that's making carter worth a pretty happy man. we'll explain why after the break. i'm here at the td ameritrade trader offices. steve, other than making me move stuff, what are you working on? let me show you. okay. our thinkorswim trading platform aggregates all the options data you need in one place and lets you visualize that information for any options series. okay, cool. hang on a second. you can even see the anticipated range of a stock expecting earnings. impressive... what's up, tim. td ameritrade. oh hey john, i'm connecting our brains so we can share our amazing trading knowledge. that's a great idea, but why don't you just go to thinkorswim's chat rooms where you can share strategies, ideas, even actual trades with market professionals and thousands of other traders? i know. your brain told my brain before you told my face. mmm, blueberry? tap into the knowledge of other traders on thinkorswim.

>> it's pfizer.iously one of the biggest health care names of all but a couple of charts to put in perspective. what i have is the s&p 500 health care sector itself and the bottom panel is relative performance. we know it's been going up off the lows in february and march. what's key is not only an absolute out or up, we think industrials and materials haven't been performing well and health care very good relative performance. and that's important. so, with this, let's look at one of the bigger names within health care. i have here the sector which we just looked at and now we've got a laggard on a long term basis. pfizer, it's lagging on a 10-year basis. a lot of this is biotech but a big player not kept up. it's lagging if you go back to the prior bull market peak of 2000, not even the 2000 -- this spread is appealing to my -- i think we want to be on the pfizer trend here. so here's your pfizer chart the here and now. it's not randomware, this is coiling right at past highs after briefly moving a

they don't have as much cash on hand as does pfizer, which has been fairly aggressive.e'll see how this plays out. let's call it by labor day, perhaps, we may get something in terms of a result here from medivation and sanofi as i said has agreed to a standstill. they've stopped trying to get written consents to solicit written consents and sit for six months. in the offhand chance that company rejects at a certain price and doesn't sell itself, they could choose to come back, we've had a pace of m&a. this has been going on for some time. the others out there, mondelez/hershey, don't have a lot to offer on either one this morning or other outstanding situations. >> big stable companies looking to do something with the cash earning zero. >> right. >> when we come back art cashin from what to expect from today's market action and some of the these research calls on airlines, news on tesla, and what you'll pay for a 30-year mort again this week in a moment. & in a world held back by compromise, businesses need the agility to do one thing & another. only at&t has the networ

why didn't i know it would be too dangerous to hold out for the allergan/pfizer merger?imple answer -- i was dpreedy. greed is just plain bad. ♪ >>> for most of tonight's show, i'm talking about what you can learn from the mistakes i've made running my charitable trust. now let's talk about what you can take away from some very specific wins that did defy the odds of investing. it's hard to remember when facebook was this company that was failing to live up to its potential, but this stock was viewed as a real loser for the first year or so after it became public. i was confused how such a smart group of people could be baffled. i watched the stock get pumme d pummeled. but i'm a huge reader, so when facebook was trading in the ththe 20s, you could tell how advertisers were flocking to it. they were in no mood to listen to the positive story. we didn't feel scorned. we weren't down, we weren't upset, we bought facebook for the charitable trust in the mid20s. how were we able to hang on? simple. each quarter showed an improvement, that it wasn't expabe expandi expanding.

still ahead on "bloomberg markets," pfizer reporting earnings, excitations are high.hares are up 14% year to date. in today's options inside, we will discover how to take advantage. this is bloomberg. ♪ vonnie: this is "bloomberg markets." i am vonnie quinn. it is time for options inside with julie hyman -- options insight with julie hyman. julie: thank you. dan is joining me from chicago. first, i want to talk about the fed today not raising rates, but they seems to be relatively optimistic about the u.s. economy. yet in the wake of it, we actually saw yields fall further on the 10-year. i am curious what you are seeing and options that explains any of this activity that we have been seeing. dan: like you said, it was a fairly benign statements, the fact that they took a diminished short-term risk i think is seen as a positive -- as a positive. the options market reacted very quickly to that type of news item, and we saw volatility elevated little bit this volatilityt excitations have been brought lower, the fix is now lower. we see not too much determination as far

m&a.e: let's talk about what has recently dominated headlines is that aligarh and -pfizer -- allergan-pfizerrought down. you have been blindsided by what happened, that now you are ready as and as this is complete. you have a lighter balance sheet right now, more cash. how are you going to spend it? brent: we were a little disappointed by the u.s. treasury's involvement of the pfizer deal, but allergan is in a good position. we are in the final stages of closing our deal to sell the golden generics business for $45 billion, and when that is closed, the proceeds will be sent -- spent 10% on a stock free purchase program, $10 billion on every payment. that will leave us with cash flow about $20 billion to invest for growth. we will be looking at buying intellectual properties, r&d assets, and of course mna. with respect to mna, it will be a smaller scale talk in deal to really support our therapeutic areas of leadership and innovation. i want to take a step back and talk about generics. player worldwide in generics. what role does generic from a cynical play in the overall generics from is it

. >> a new report out that pfizer has agreed to a written code of conduct when it comes to the marketingly behind that move? >> it's kind of incredible. basically what you have here is the city of chicago suing several drugmakers including the drugmaker behind the drug oxycontin. they basically said this hasn't only affected people but has cost the city millions of dollars in insurance payouts as people work to work through the addictions to these kinds of drugs and of course while pfizer itself only has one opioid on the market industry insiders say that this is a great first move and they're hoping that other drugmakers are going to follow suit. >> all right. could be the start of something big. hadley gamble live from london thank you so much. >>> all right still ahead before the iphone or the galaxy there was this thing called blackberry. we'll tell you why that iconic brand will never be the same. ♪ using 60,000 points from my chase ink card i bought all the framework... wire... and plants needed to give my shop... a face... no one will forget. see what the power of points can do fo

it is part owned by pfizer.ending which is a blockbuster for multiple sclerosis treatment. that really integrates was going to be the main focus of those activities. you said: thank you. angie: the japanese prime minister has revealed his latest joining us right now is our chief asia correspondent. in that it wasl not an organized media rollout. he just spoke off-the-cuff. >> usually he is trying to steal the limelight or centerstage stage or big tv channel. t(it was carrying a high school baseball game. rather than announcing this massive fiscal stimulus package. getting sense of what is going on with the government's push to take action before they have all the details ready. his government lost narrative. maybe they should just put that in there putting some pressure on the bank of japan. we have several hours to go before the bank of japan announces its decision. what is new in that package. does give any details. as for the call fresh water. the other problem is that people say they tend to not need extra s

pfizer 3.3% div geidend yield. pfizer case, great and's growing oncology franchise.el, interesting. reporting after the close. verbiage ike looking for, what's going on with them and the iphone 7. qualcomm, what's going on in china? signed that great settlement late last year. started a sign up of a lot of chinese smartphone oems. is it them. >> pete. chips more broadly. >> i like the chips in general. been in and out of micron many times. the one problem i have with qualcomm has been this stumble that seems to happen quarter after quarter after quarter. >> it does, doesn't it? >> but there are other names out there that have been absolutely explosive. some reporting and some will be reporting. >> pete, i think they've stumbled so many times it's actually priced into the stock right now it's stumbled. >> on intel it's run back into resistance at 36. it makes sense for it to pause here. but rsi is climbing. >> coming up. pete najarian has some unusual activity, what he's seeing, whether you should be a buyer as well. >>> "halftime report" with scott wapner is the plac

pfizer, tesla, fitbit.y. >> this stock recently has in the last weeks hit a 12-year high and that was a long time ago. that was back when it had lipitor. it will be curious to see if the oncology drugs which is really what it's been focusing on power it to all-time highs. >> mgm next week when you look at results delivered by win that could get -- >> tesla, scott's miracle gro. tesla i'm definitely going to be interested to hear what they have to say and if they have to guide on the production numbers, judge. >> yeah there. guys, have a great one. >> you too. >> we'll be keeping our eye on the market. there's the dow in negative territory. s&p is positive. have a great weekend. power starts now. >>> and welcome to "power lunch." i'm michelle caruso-cabrera. here's what's on the menu. a 1% economy and a stock market running out of steam after a hot start to the month. so should investors fear these dog days of august? we'll debate. the parties are over, the convention parties that is, now the dog fight begin

i'm looking at large cap pharma, steph, thinking pfizer, bristol-myers. i own pfizer. boring stocks. own them for the yield. all have good yield, sort of in the 3% range. all three breaking out recently. pfizer looking at a multiyear high here soon and defensive in what have been volatile times. the main news for all three, very strong in oncology, and cancer medicine is something that's going to be growing for at least the foreseeable future. so i like being in these names. they're cheaply valued, good growth potential and great yields. >> watching shares of tesla, meantime. virtually flat today and this as u.s. regulators launch an investigation into the car's autopilot feature after a driver was killed in florida. our phil lebeau has the latest on this developing story. >> melissa a number details coming out giving a better sense what happened when this accident took place may 7th. video of the driver that he posted on youtube, on the "today" show driving his model s. not the day of the accident. this is prior to that, of him saying, look, i love my model s and you'

i'm liking pfizer. it's doing many things right. >> hmm.od weekend. >> you, too. >> we'll see you tonight and monday. when we come back, more on google and amazon's big beats. google on earnings. the head of expedia in a moment. gain the freedom to fumble with the new water and shatter-resistant samsung galaxy s7 active. exclusively at at&t. there's a lot of places you never want to see "$7.95." [ beep ] but you'll be glad to see it here. fidelity -- where smarter investors will always be. if only the signs were as obvious when you trade. fidelity's active trader pro can help you find smarter entry and exit points and can help protect your potential profits. fidelity -- where smarter investors will always be. ♪ just got paid just got paid friday night friday night ♪ >>> good friday morning. welcome back to "squawk on the street." i'm carl quintanilla. final trading day of the month. historically weak for the s&p the last couple of years. we're down about three points. >> we have breaking economic data. rick santelli is live in chicago. >> t

tim collins on an off the chart segment said you know what, jim, you ought to take a hard look at pfizerthe world's largest pharmaceutical company would be the kind of company i would shun, i would normally never touch this thing when the economy's speeding up, but if you take a look at this chart, you can see that pfizer traced out a left shoulder as it rallied through the month of october, then started declining aggressively. in november, and then a pull back to create the right shoulder. the key with this pattern is the neckline. the line that connects the head to the two shoulders. when a stock breaks out ahead that, it indicates a big, big move. bottom line was $25.80. given that money was pouring out of the staples and drug stocks, i was confounded by this head and shoulders pattern. i knew it was a bad stock. but collins said rotations, smotations. something big was going on. i thought it was inconceivable. sure enough, he was right. i was wrong. the stock almost instantly jumped more than 10% after collins told me to buy it with both hands. soon after he flagged this bullish reve

treasury's involvement of the pfizer deal, but allergan is in a good position. final stages of closing our deal with teva to sell the golden generics business for $45 billion, and when that is closed, the proceeds will be spent 10% on a stock free purchase program, $10 billion on debt repayment. that will leave us with cash flow of about $20 billion to invest for growth. we will be looking at buying intellectual properties, r&d assets, and of course m&a. with respect to m&a, it will be a smaller scale tuck and deal to really support our therapeutic areas of leadership and innovation. david: i want to take a step back and talk about generics. because mylan is a major player worldwide in generics. what role does generics from a cynical play in the overall business and, for that matter, with people? heather: they play a very significant part around the globe. if we start in the united states, generics have become the backbone of the health-care system. we represent 80% of all the drugs in the united states. as you work your way around globally, different parts have

. >>> abc news "nightline," brought to you by pfizer.smoking with chantix. i have smoked for 30 years and by taking chantix, i was able to quit in 3 months and that was amazing. along with support, chantix (varenicline) is proven to help people quit smoking. it absolutely reduced my urge to smoke. some people had changes in behavior, thinking or mood, hostility, agitation, depressed mood and suicidal thoughts or actions while taking or after stopping chantix. some had seizures while taking chantix. if you have any of these, stop chantix and call your doctor right away. tell your doctor about any history of mental health problems, which could get worse or of seizures. don't take chantix if you've had a serious allergic or skin reaction to it. if you have these, stop chantix and call your doctor right away as some can be life-threatening. tell your doctor if you have heart or blood vessel problems, or develop new or worse symptoms. get medical help right away if you have symptoms of a heart attack or stroke. decrease alcohol use while taki

pfizer just announced they're leaving the united states. it's a great company.zer, so many companies are leaving the united states. carrier is a disgraceful situation. they announced they're laying off 1,400 people. they're going to mexico. they're going to build a plant. there's only one way you're going to stop that. it was on television all over the place because somebody was using one of their famous telephone cameras. you look at those 1,400 people. they were devastated. they were there for years and years, and they were devastated. they said, no, we're folding up and we're going to go to mexico. i said there's only one way of solving that problem. now, the conservatives would say, oh, he's not a free trader. i'm a great free tader but it has to be smart trade and fair trade. you say to them, enjoy your stay in mexico. but every air conditioner that you make that comes tiny this country, you're going to pay a 35% tax. you know what's going to happen? they're not moving. honestly, the politicians, they want to do legislation because they know it's a problem.

. >>> "good morning america" is brought to you by pfizer. u by pfizer. i'm billy, and i quit smoking with chantix. i had a lot of doubts going in. i was a smoker. hands down, it was, that's who i was. after one week of chantix, i knew i could quit. along with support, chantix (varenicline) is proven to help people quit smoking. chantix definitely helped reduce my urge to smoke. some people had changes in behavior, thinking or mood, hostility, agitation, depressed mood and suicidal thoughts or actions while taking or after stopping chantix. some had seizures while taking chantix. if you have any of these, stop chantix and call your doctor right away. tell your doctor about any history of mental health problems, which could get worse or of seizures. don't take chantix if you've had a serious allergic or skin reaction to it. if you have these, stop chantix and call your doctor right away as some can be life-threatening. tell your doctor if you have heart or blood vessel problems, or develop new or worse symptoms. get medical help right away if you have symp

pfizer and proctor and gamble pbl. the biggest release comes friday with july's employment report. investors lpt to see if the bounceback we saw in the last report has held and that's what to watch for next week. >> start ups are settling down just north of california. portland oregon is fast becoming an entrepreneurial hub for health and fitness companies and lies of course in the shadows of nike's headquarters. kate rogers is in portla >> while the u.s. men's gy a the international in rio, one start up in portland is helpin. >> wearable technologies created custom wearables for team usa to do more than just count steps. these devices study the quality of each step analyze the day to to enhance performance. >> we can capture the gymnast running up to a vault and so we can look at and characterize their wod di movement, so looking at efficiencies. so are we trying to improve their speed, let's look at efficiencies or trying to improve their rotations, let eat look at their form. technolog made portland a great pl ho loca resources like the portland state university business acceler

merk, pfizer, lily. >> the bottom panel is its relative performance, the stock to its peer group, the ibb. engi amgen peeked a year ago in august. since that peak, it's out performed the ibb and that's very important. meaning, it's a defensive a fai group. here is the actual chart itself on the long-term basis. again you can draw is the lines any way you want. my eye sees that. when you have a standoff. bears and bulls are very much matched off. a series of low or highs. people make the bet this is going to do this and that's what makes a market. i'll take the other side of that. i think the uptrade the coming based on how good the relative performance has been. soy want to zero in on this long-term wedge more immediately. here is base of the action of the past year and a half. here's our all-time high. went to about 17.81. let's draw some lines. no lines, lines. i think we're going to do it. i'm going to play for the past high at 181. sort of an offensive, defensive low beta name. >> that would be quite some upside. >> i do think we're in a world right now where it's hard to imagine

this stock is more parlayed with some of the lower beta names like pfizer lily. okay.op panel is amge nrn and the bottom to its peer group. it piqued at $81 in august. since that as it has gone down on an absolute basis, that's very important. it's a defensive name in a fairly aggressive group and that's going serve you well if one were to do this trade. here is the actual chart itself on the long-term basis my eye seeing that. i think we're going to resolve this. there are plenty of people that make the bet this is going to do this. i'll take the other side. i think the uptrade is coming based on how good the relative performance has been. here's the action. no lines, line, i think we're going to do it. sort after an offensive, defensive large low beta name. >> mike? >> so, i do think, to dan's point, we're in a world now where it's hard to imagine what the good news for any stock is going to be, but in some like the financial, i wonder whether there's a a lot of bad news baked in. i've seen the chart going sideways. going make a mildly bullish bet because it could in

this stock in particular is more correlated with some of the big lower beta names like merck, pfizer, lily. the bottom panel is its relative performance to its peer group. amgen 81 dollars in august. a year ago since that peak, as it has gone down on an absolute basis, it has outperformed the ibb and that is very important. meaning it's a defensive name within a fairly aggressive group. and i think that is going to serve you well if one were to do this trade. here is the actual chart itself on the long-term basis. you can draw the lines any way you want. my eye sees that and i think we are going to resolve this. keep in mind that when you have a standoff. bears and bulls are very much matched off. a series of high or lows or highs or lows. many people bet it's going to do this and that makes a market. i take the other side. i think the uptrade is coming based on how good the relative performance has been. i want to zero in on this long-term wedge more immediately. here is base of the action of the past year and a half. here is our all-time high. 181. again, let's draw some lines. so n

pfizer is the world's second largest drug company.ed to disclose promotional material that narcotic painkillers carry serious risk of the drugmaker will also acknowledge no good research on opioids effectiveness beyond 12 weeks. >>> hillary clinton says using a private e-mail server while she was secretary of state was a mistake but insisted more than a year nothing was wrong with it. jan crawford looks at clinton's own statements that the fbi investigation found to be untrue. jan, good morning once again to you. >> reporter: good morning. the clinton campaign is now saying the e-mail case, that is closed. but the fbi director is flat-out rejecting many of the arguments she has made as she tried to reassure voters she did nothing wrong. >> there is no classified material. there was no transmission of any classified information. >> reporter: from the beginning, hillary clinton has been adamant about what was not on her private server. >> the facts are pretty clear. i did not send, nor receive, anything that was classified at the time.

. >> i want to know what you think about pfizer as a long-term investment for my ira?ey have a good growth and good pipeline, 3% yield. i think this is the ideal retirement stock that i like to talk about on mad money. well done. rick in arizona. rick. >> hi, jim. jim, i am in a quandary regarding my holdings of smith and wesson, do i hold my personal target of $34 or pull the trigger selling now and reap 65%? >> this is a excellent company. i am not talking pro or anti- gun. they are very good at what they do and the stock has further to run. i would not ring the register. sometimes it jumps. i think it is ahead of itself and i think they represent a good investment. >> booya mr. cramer. i am calling to discuss american airlines, this is one of the first stocks i bought in 2014 when i worked up the courage to invest in the stock market. they beat estimates and announced they brought back shares in the quarter and delayed receiving new aircraft until 2018. with the positive news from the earnings report should i increase my position in american airlines? >> when i hear

. >> health casework an interest in pfizer and amgen. >> so you won't need to buy gold bond powder if you treat your body properly. i've really enjoyed being with you guys. it's a tough show to do. looks like our time has ek >>> my mission is simple. to make you money. i'm here to level the playing field for all investors. there's always a bull market somewhere, and i promise to help you find it. "mad money" starts now! >>> hey, i'm cramer. welcome to "mad money." welcome to cramerica. other people want to make friends. i just want to make you some money. my job is not just to entertain you but to educate you. so call me at 1-800-743-cnbc. you thought we done with earnings. forget about it. sure, we have vulcan materials kicking things off on monday, and this maker of aggregates, also known as stone, is going to tell a pretty good story. vulcan does well when there is construction in the company and highway billsening pa ebeing pa. right now we have both. and then we go to caterpillar, because construction is booming. i know that many of you at home are hungry for yield. which is why

drug stock that caused people to lose a huge amount of money, and that's all because the merger with pfizert go through. look at that rite aid thing. including the idea that maybe allergan had to do a deal or its growth is going to slow. at least until the company closes, transaction i expect to get done any day now. i've been saying that for a month. i'm concerned. finally, number ten. all we need to see disney to get some traction. the skinny bundle, skin eny bon bill issues aren't slowing. will the bears be right that the cable companies are going to start paying dramatically less to carry espn. that with swamp shanghai disney as well as the film franchises. hey, sorry, they are one and the same. here's bottom line. these ten stocks speak volumes about why so many people are skeptical of the move. sure, we've had our post-brexit rebound, but it won't hit home. without them, we're not going to bra break out the levels what a bull market represents to the vast majority of observers. including yours truly. >>> all right, on mad tonight, these stocks were at the about the -- bottom. alcoa ki

brx, some of it's related to the busted pfizer allergan merger.ow, there were still pockets of strength in health care, which is why the whole health care sec for was down. and the medical device makers. consider the top five performers in health care and you'll get what i'm talking about. at mum one, strooiker. another med tech is up. thanks to the minimally invasive defib later. the first best, one of our old favorites, st. jude, bye, st. jude, it's agreed to be acquired by abbott labs. what about the fourth strongest, care to guess? it's medical technology company heart valve that can be installed via catheter versus cracking the chest. noticing a pattern here? while the best-performing health stocks were medical device stocks, all struggling pharmaceuticals, biggest loser was endo, make being ing it the performer. suddenly, it became incredibly obvious when the company took a hatch elt to its full-year guidance in early may. of' also got the number one maker of knockoff of the counter drugs. it got slammed when the long-time ceo left abruptly

pfizer and the pfizer amendment act have been congress's answer to providing the executive to a structureimiting principles and how we conduct foreign surveillance. the pfizer amendment act hasn't provided the type of protection that are needed on violence and ultimately reasonable under the fourth amendment. the act permits us to conduct surveillance, targeting foreign persons located outside of the united states. the targeting procedures also require that the nsa analysts do due diligence and ensure that both of those requirements are met and that the surveillance is conducted for the purpose of obtaining foreign intelligence information, and that it's reasonable to believe that foreign intelligence information will in fact be found. >> you say faa allows the targeting of foreign individuals per the targeting is not done as it is under fish with approval. it's done in a topical sense and the selection of the target is done without the initial approval and only by agents of the executive branch, true. >> accurate, but there is in fact rigorous internal oversight and there is oversight on

. >> it's talking about apple, pfizer, microsoft. trish: let me ask you this because you know hillary clinton is going to push back on this, well, you know, companies are incentivize, basically use that money in a way that's not necessarily right, going to benefit actual workers. >> we did it in 2004. some of it went to the benefit of shareholders. what's wrong with that? how many people are shareholders in this country? >> about half. >> we did see companies build factories with that money. why do we want it in china? >> hillary should take the blame for this law. this could have been fixed, obama told a lot of the business that he was going to fix it. it's been eight years. he's never move to help at this at all. i think it's time that they got out of the way. >> trish, i'm not entirely sure this will be the argument from the clinton campaign. that's fine, let's do the tax -- >> maybe there's a deal there. >> trump wants to build more -- i want to inform you guys about something else and get your reaction to it. and one of the big

. >>> while researching treatments for high blood pressure and heart disease, the drug company pfizerccidentally develops a life changing pill, viagra. >> turns out it has a side effect, erections. >> viagra was a big deal, not only because it helped to treat erectile dysfunction but it made that condition part of the national condition. >> sales have quadrupled since its watch but there is no equivalent for the other half of the population. >>> coming up -- >> it really did introduce a new era, if you will, of mass shootings at schools. >>> i'm todd piro. here's what's happening. hillary clinton's running mate is senator tim kaine of virginia. the two are expected to appear together at a rally later in miami. they campaigned together in virginia last week. >>> a shooting rampage at a shopping mall in munich, germany, left nine victims dead and others hurt. he was an 18-year-old who lived in the city for more than two years but was not previously known to police. now back to our program. >>> for 20 years msnbc has covered the biggest news stories and how they continue to impact our li

. >>> while researching treatments for high blood pressure, pfizer develops a life changing little blue pill. in 1998, viagra is approved by the fda. >> it turns out there was a side effect that a lot of the initial patients had. they developed erections. and the pharmaceutical companies realized this is a much better place to market than just another blood pressure pill. >> it not only helped to treat erectile dysfunction, but made it part of the national conversation. >> there is still no equivalent for the other half of the population. >>> coming up -- >> it really did introduce a new era if you will of mass shootings at schools. >>> i'm dara brown. thousands of mourners gathered in texas at a funeral service for the officer zamarripa. he was fatally killed last week. he was married with two children. >>> secretary john kerry says that the u.s. will consider an extradition request for the cleric fethullah gulen in connection with the failed military coup in turkey. president erdogan blames him for the coup and gulen denies any involvement. now back to our msnbc special. >>> for 20 ye

. >> while researching treatments for high blood pressure and heart disease, the drug company pfizeridently develops a life-changing little blue pill. in 1998, viagra is approved by the fda. >> turns out there was a side effect that a lot of the initial patients had. they developed erections. they decided this is a much better place to market than just another blood pressure pill. >> viagra not only helped treat erectile dysfunction, but made that condition part of the national conversation. >> sales of viagra have quadrupled since its launch. but there is still no equivalent for the other half of the population. >>> coming up -- >> it really introduced a new era, if you will, of mass shootings at schools. you both have a perfect driving record. until one of you clips a food truck. then your rates go through the roof. perfect. for drivers with accident forgiveness, liberty mutual won't raise your rates due to your first accident. liberty mutual insurance. >>> i'm richard lui. >>> governor mike pence back in his home state of indiana after accepting the vp nod officially in new york f

. >> while researching treatments for high blood pressure and heart disease, the drug company pfizertally develops a life-changing little blue pill. in 1998, viagra is approved by the fda. >> turns out there was a side effect that a lot of initial patients had. p. they developed erections and the pharmaceutical companies quickly realized that's a much better place tore us to market than just another blood pressure pill. >> it was a big deal because it treated erectile function and made that condition part of the national conversation. >> sales of viagra is quadrupled since its launch but there is still noquiv for the other half of the population. coming up -- >> it did introduce a new era, if you will, of mass shootings at schools. >> i'm alex trebek. if you're age 50 to 85, i have an important message about security. write down the number on your screen, so you can call when i finish. the lock i want to talk to you about isn't the one on your door. this is a lock for your life insurance, a rate lock, that guarantees your rate can never go up at any time, for any reason. but be caref

. >> while researching treatments for high blood pressure and heart disease, the drug company pfizery develops a little blue pill. in 1998, viagra is approved by the fda. >> turns out there was a side effect that a lot of the initial patients had that developed erections and the pharmaceutical companies realized it's a much better place to market than a blood pressure pill. >> viagra really made erect i'll disfunction part of the conversation. >> sales of viagra quadrupled since its launch, but there is still no equivalent for the other half of the population. >>> coming up. >> what really did introduce a new era, if you will, of mass shootings at schools. . d sure...but don't get just any one. get one inspired by dentists, with a round brush head. go pro with oral-b. oral-b's rounded brush head cups your teeth to break up plaque and rotates to sweep it away. and oral-b delivers a clinically proven superior clean versus sonicare diamondclean. my mouth feels super clean! oral-b. know you're getting a superior clean. i'm never going back to a manual brush. if you have moderate to sever

goldman sachs, apple, pfizer, jpmorgan who beat, the biggest winners on the dow today. good day.ll: very good. the never trump movement such as it is would be its final stand, a last minute effort to stop trump at the convention. it's underway. it was actually all delayed today, in a kind of a weird, paper jam of printer jam of some sort out in cleveland where blake burman is standing by for us. he has latest on all that. hey, blake. reporter: no need to brink a printer when you come here to cleveland next week, this was all a 10-minute printer error. that is with we were told this morning. there was a printer jam. it was just for ten minutes. we figured at the time what played out. they just used whole thing as a ruse to give a little it about of a break here to the rules committee. so 9:00, the whole thing stopped as the rules committee was supposed to meet this morning. that allowed for basically the rnc, some of its members, grassroots activists, how it was described to me, to get into a room, a closed-door scenario, and try to hammer out some of the disagreements that they h

zts spun off by pfizer in early 2013. the stock had a lack luster first year but rallied in 2013, 11% in 2015 and is up 3% year to date. including a very good companion animal sales line and they are inventive coming up with new medicines. next up, cramer fave idexx labs. this is the maker of veterinary testing equipment, the world's leader in diagnostic tools for animals. idexx has been a tremendous winner going back to the financial crisis. look at the chart. stock keeps roaring year after year including a 20% plus gain in 2016. the company continues to churn out solid results. it is riding the pet theme. most recently they reported a nice beat and raise quarter in april. it made good money if you bought the stock when john ayers appeared after the brexit thing. of course pets had nothing to do with brexit but the stocks fell anyway. third, vca, victor charlie anthony. that's the aptly tickered woof! originally short for veterinary centers of america, it runs 680 small animal vet hospitals in the u.s. and canada. they h

. >> while researching treatments for high blood pressure and heart disease, the drug company pfizervelops a little blue pill. in 1998, viagra is approved by the fda. >> turns out there was a side effect that a lot of the initial patients had that developed erections and the pharmaceutical companies realized it's a much better place to market than a blood pressure pill. >> viagra really made erectile disfunction part of the conversation. >> sales of viagra quadrupled since its launch, but there is still no equivalent for the other half of the population. >>> coming up. >> what really did introduce a new era, if you will, of mass new era, if you will, of mass shootings at schools.ou're clarence! yes, sir. you know, at the model year end clarence event, you can get a great deal on this 2016 passat. steve. yeah? clarence is on a roll. yeah. i wish they'd name an event after me. same here. but the model year end becky event? that's no good... stevent! that's just vandalism. whatever you want to call it, don't miss the volkswagen model year end event. hurry in for a one-thousand dollar vo

. >> while researching treatments for high blood pressure and heart disease, the drug company pfizer accidentally develops a life-changing little blue pill. in 1998 viagra is approved by the fda. >> it turns out there was a side effect that a lot of the initial patients had. they developed elections, and the pharmaceutical companies quickly realized that's a much better place for us to market than just another blood pressure pill. >> it was a big deal because it treated erectile function and made that condition part of the national conversation. >> sales of viagra have qu quadrupled since its launch, but there is still no ee kwib lent for the on half of the population. >>> coming up -- >> it did introduce a new era, if you will, of mass shootings at schools. just say, show me cars with only one owner pretty cool it's perfect. that's the power of carfax® find the cars you want, avoid the ones you don't plus you get a free carfax® report with every listing start your used car search at carfax.com i'm not a customer, but i'm calling about that credit scorecard. (to dog)give it. sure! it

. >> while researching treatments for high blood pressure and heart disease, the drug company pfizerdevelops a life changing little blue pill. in 1998, viagra is approved by the fda. >> turns out there's a side effect a lot of initial patients had. they developed erections and the pharmaceutical companies thought there was a much better place to market than another blood pressure pill. >> viagra helped to treat erectile dysfunction but made that condition part of the national conversation. >> sales of viagra quadrupled since its launch but no equivalent for the other half of the population. >>> coming up -- >> really did introduce a new era, if you will, of mass shootings at schools. ♪ ♪ (vo) you can pass down a subaru forester. (dad) she's all yours. (vo) but you get to keep the memories. love. it's what makes a subaru, a subaru. kellogg's® frosted 8 layers of wheat... and one that's sweet. for the adult and kid in all of us. ♪ kellogg's frosted mini-wheats® feed your inner kidult and i quit smoking with chantix. i have smoked for 30 years and by taking chantix, i was able to quit i